跳至主要内容
临床试验/NCT00899119
NCT00899119Unknown不适用

Autologous Stem Cell Harvesting for Waldenstrom's Macroglobulinemia

Herbert Irving Comprehensive Cancer Center1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2005年11月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
试验地点
1
主要终点
Number of days to adequate stem cell harvest

研究概览

简要总结

RATIONALE: Collecting and storing stem cells to study in the laboratory may help doctors learn more about collecting stem cells from patients who have undergone treatment for Waldenstrom's macroglobulinemia.

PURPOSE: This laboratory study is collecting stem cells from patients with Waldenstrom's macroglobulinemia.

详细描述

OBJECTIVES:

  • Harvest and store adequate CD34+ stem cells from patients with Waldenstrom's macroglobulinemia (WM) for potential future use in transplantation strategies.
  • Evaluate the ability to harvest stem cells after therapy for WM (e.g., fludarabine-based chemotherapy) by evaluating the number of days to adequate harvest.
  • Collect aliquots of stem cells for future research analysis as part of a WM database project.

OUTLINE: Patients undergo collection of autologous stem cells beginning on day 4 or 5 and continuing until an adequate number of stem cells are collected. Cells are then cryopreserved.

PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Number of days to adequate stem cell harvest

次要结局

未报告次要终点

研究者

发起方
Herbert Irving Comprehensive Cancer Center
申办方类型
Other

研究点 (1)

Loading locations...

相似试验